New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
09:14 EDTRAD, F, ENDP, MU, PATH, FRX, TWTR, STZ, MCD, JCP, MSFT, TCS, TEVAOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Micron (MU), up 10%... Constellation Brands (STZ), up 7%... Apollo Education (APOL), up 8%. ALSO HIGHER: Forest Laboratories (FRX), up 14% after acquiring Aptalis for $2.9B in cash... Rite Aid (RAD), up 2.6% following upgrade at JPMorgan... NuPathe (PATH), up 36% after receiving takeover bid from Teva (TEVA) to rival formerly agreed to deal with Endo Health (ENDP)... Ford (F), up 1.6% after AP says CEO Mulally staying at Ford. Microsoft (MSFT), down 0.6% after the news, as Mulally was viewed as a candidate for its CEO opening... ALSO LOWER: The Container Store (TCS), down 10.4% after earnings, downgrade at BofA Merrill Lynch... J.C. Penney (JCP), down 6.3% after backing Q4 outlook but not providing December same-store sales figure... Twitter (TWTR), down 4% following downgrade at Cantor... McDonald's (MCD), down 1% following downgrade at Wells Fargo.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 >>
September 23, 2015
09:55 EDTFActive calls on open: BIIB FCX X F INTC
Subscribe for More Information
09:18 EDTMSFTPaulson Institute and CCPIT to co-host U.S.-China Business Roundtable
The Paulson Institute and the China Council for the Promotion of International Trade (CCPIT) provide an opportunity for U.S. and Chinese business leaders to discuss issues facing the two countries in a roundtable being held in Seattle, Washington on September 23.
08:24 EDTENDPWeakness in drug stocks creates buying opportunities, says RBC Capital
After Hillary Clinton unveiled a plan to lower drug prices, RBC Capital does not expect the plan to be passed by Congress. The firm adds that the plan is positive for generic drug makers and could pressure the FDA to more quickly approve generic drug applications. RBC identifies Insys Therapeutics (IINSY), Endo (ENDP), and Sagent Pharma (SGNT) as three stocks it likes that have suffered "disproportionate selloffs over the last two days." The firm identifies Sagent, Emdo and Mylan (MYL) as three companies with high generic exposure that have sold off.
08:07 EDTMSFTDataStax announces strategic collaboration with Microsoft
DataStax announced a strategic collaboration with Microsoft to deliver Internet of Things, Web and mobile applications in public, private or hybrid cloud environments. With DataStax Enterprise available on Azure, Microsoft's cloud computing platform, enterprises can quickly build high-performance applications that can massively scale and remain operationally simple across public and private clouds, with ease and at lightning speed.
07:08 EDTJCPJ.C. Penney names John Tighe chief merchant
Subscribe for More Information
06:37 EDTJCPJ.C. Penney seeks new chief merchant to replace Sweney, WSJ reports
J.C. Penney is searching for a new chief merchant, The Wall Street Journal reports, citing sources familiar with the matter. The new executive would replace Elizabeth Sweney, who has held the role since 2012. It is unclear whether the new chief merchant would be an internal or external candidate, but one source says that an announcement relating to the role will be made "early Wednesday morning." Reference Link
September 22, 2015
16:00 EDTMU, FOptions Update; September 22, 2015
Subscribe for More Information
14:07 EDTTWTRTwitter Sr. Director of Engineering Akash Garg leaving company
Subscribe for More Information
10:45 EDTRADReimbursement pressure on drug stores should moderate, says Cleveland Research
Cleveland Research analysts Rob Eich and Rob Stuyck said the firm's work indicates that stepdown reimbursement rates will be more manageable for drug store operators and that generic inflation will be less of a headwind for the group in FY16. However, Direct and Indirect Remuneration clauses will still be a source of margin pressure, the firm said, noting that several payers will be introducing a DIR next year. Cleveland Research has Neutral ratings on CVS (CVS), Walgreens (WBA), Rite Aid (RAD) and Wal-Mart (WMT).
10:45 EDTTWTRStocks with call strike movement; TWTR NFLX
Subscribe for More Information
09:33 EDTMU, MSFTActive equity options trading on open
Subscribe for More Information
08:23 EDTTEVAWith Pharma in 'hot seat,' Citi still likes Allergan, Teva
Subscribe for More Information
07:43 EDTTEVADrug stocks could be hurt by focus on pricing, says Oppenheimer
Subscribe for More Information
07:41 EDTMURaymond James to hold a conference
North American Equities Conference to be held in London, England on September 22.
07:38 EDTRADUBS to hold a conference
Healthcare Supply Channel & Tech Conference is being held in Boston on September 22.
07:15 EDTMSFTCloudFlare raises $110M from consortium of Google, Microsoft, others
Subscribe for More Information
06:40 EDTMUChip sector deal size up substantially in 2015, WSJ reports
Subscribe for More Information
06:20 EDTTEVALeerink reiterates Outperform on Neurocrine after call with neurologists
Leerink analyst Paul Matteis reiterates an Outperform rating on Neurocrine (NBIX) after speaking with two neurologists on the clinical potential of the company's NBI-98854 and Teva's (TEVA) SD-809 for the treatment of Tardive Dyskinesia, Tourette's Syndrome and Huntington's Chorea. Matteis left the call "increasingly optimistic" on the likelihood of NBI-98854 showing Phase III success for Tardive Dyskinesia. The analyst has a $67 price target for shares.
05:54 EDTMUDRAM price declines likely to continue through 2015, says Piper Jaffray
Subscribe for More Information
05:14 EDTMSFTIngram Micro to participate in Microsoft Cloud Solution program in India
Ingram Micro (IM) announced its participation in the Microsoft (MSFT) Cloud Solution Provider program in India. The program is designed to strengthen customer relationships and expand cloud sales by allowing channel partners to provision, bundle, invoice, manage and support Microsoft cloud offerings including Microsoft Office 365, Windows Intune, Enterprise Mobility Suite, Azure, and CRM online subscriptions with greater ease and efficiency.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use